Researcher.Life Logo

The Midwest Quarterly : Impact Factor & More

eISSN: 0026-3451pISSN: 0026-3451

Key Metrics

CiteScore
0.2
SNIP
0.03
Recommended pre-submission checks
Powered by Paperpal by Editage

The Midwest Quarterly Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
Overview
Publisher PITTSBURG STATE UNIV
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1959
View less

Planning to publish in The Midwest Quarterly ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Midwest Quarterly

Coordinated DNA 5-mC and RNA m5C methylation epigenetically regulates MZF1 splice variants to drive EGFR-TKI resistance.
  • 1 Jul 2026
  • Experimental & molecular medicine
Therapeutic effect of intranasal nicotinamide adenine dinucleotide in the restoration of olfactory dysfunction.
  • 1 Jul 2026
  • Experimental & molecular medicine
Metabolic reprogramming of myeloid cells in cancer: from lactate-NAMPT axis to AI-guided therapeutics.
  • 1 Jul 2026
  • Experimental & molecular medicine
Author Correction: TGF-β promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways.
  • 29 Jun 2026
  • Experimental & molecular medicine
Retraction Note: Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
  • 29 Jun 2026
  • Experimental & molecular medicine
Metastasis-related genomic aberrations and evolutionary trajectory in uveal melanoma.
  • 17 Jun 2026
  • Experimental & molecular medicine
Coordinated DNA 5-mC and RNA m5C methylation epigenetically regulates MZF1 splice variants to drive EGFR-TKI resistance.
  • 1 Jul 2026
  • Experimental & molecular medicine
Therapeutic effect of intranasal nicotinamide adenine dinucleotide in the restoration of olfactory dysfunction.
  • 1 Jul 2026
  • Experimental & molecular medicine
Metabolic reprogramming of myeloid cells in cancer: from lactate-NAMPT axis to AI-guided therapeutics.
  • 1 Jul 2026
  • Experimental & molecular medicine
Author Correction: TGF-β promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways.
  • 29 Jun 2026
  • Experimental & molecular medicine
Retraction Note: Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
  • 29 Jun 2026
  • Experimental & molecular medicine
Metastasis-related genomic aberrations and evolutionary trajectory in uveal melanoma.
  • 17 Jun 2026
  • Experimental & molecular medicine

FAQs on The Midwest Quarterly